Published in Proc Natl Acad Sci U S A on May 01, 1977
Studies in porphyria. VII. Induction of uroporphyrinogen-I synthase and expression of the gene defect of acute intermittent porphyria in mitogen-stimulated human lymphocytes. J Clin Invest (1978) 1.05
Secretion of haem by hepatic parenchymal cells. Biochem J (1979) 0.93
Bovine protoporphyria: documentation of autosomal recessive inheritance and comparison with the human disease through measurement of heme synthase activity. Am J Hum Genet (1982) 0.90
The role of cytosolic proteins in the intracellular transport of haem in rat liver. A dual-label approach. Biochem J (1982) 0.85
Acute Hepatic Porphyria. J Clin Transl Hepatol (2015) 0.80
Comparison of human and bovine protoporphyria. Yale J Biol Med (1980) 0.79
Incorporation of haemoglobin haem into the rat hepatic haemoproteins tryptophan pyrrolase and cytochrome P-450. Biochem J (1986) 0.75
The induction in vitro of the synthesis of delta-aminolevulinic acid synthetase in chemical porphyria: a response to certain drugs, sex hormones, and foreign chemicals. J Biol Chem (1966) 5.70
Increase in activity of alpha-aminolevulinic acid synthetase in liver mitochondria induced by feeding of 3,5-dicarbethoxy-1,4-dihydrocollidine. J Biol Chem (1963) 4.35
ACUTE INTERMITTENT PORPHYRIA: THE FIRST "OVERPRODUCTION DISEASE" LOCALIZED TO A SPECIFIC ENZYME. Proc Natl Acad Sci U S A (1965) 2.34
Heme biosynthesis in intermittent acute prophyria: decreased hepatic conversion of porphobilinogen to porphyrins and increased delta aminolevulinic acid synthetase activity. Proc Natl Acad Sci U S A (1970) 2.33
Cobalt stimulation of heme degradation in the liver. Dissociation of microsomal oxidation of heme from cytochrome P-450. J Biol Chem (1975) 2.05
THE EFFECT OF CARBOHYDRATE FEEDING ON THE INDUCTION OF DELTA-AMINOLEVULINIC ACID SYNTHETASE. Metabolism (1964) 1.51
The serum porphobilinogen and hepatic porphobilinogen deaminase in normal and porphyric individuals. J Lab Clin Med (1971) 1.47
Oscillations of hepatic delta-aminolevulinic acid synthetase produced in vivo by heme. Biochem Biophys Res Commun (1966) 1.46
Biochemical defects in two types of human hepatic porphyria. N Engl J Med (1970) 1.46
Onset of manifestations of hepatic porphyria in relation to the influence of female sex hormones. Arch Intern Med (1966) 1.43
Repression of the overproduction of porphyrin precursors in acute intermittent porphyria by intravenous infusions of hematin. Proc Natl Acad Sci U S A (1971) 1.33
Effect of hematin in acute porphyric relapse. Ann Intern Med (1973) 1.19
Effects of hematin in hepatic porphyria. Further studies. Ann Intern Med (1975) 1.14
The primary enzyme defect in hereditary coproporphyria. Lancet (1976) 1.08
Acute porphyria: a neuropsychiatric and biochemical study. J Psychosom Res (1962) 1.06
The enzymatic conversion of hemoglobin to bilirubin. Trans Assoc Am Physicians (1969) 1.04
Repression by hematin of porphyrin biosynthesis in erythrocyte precursors in congenital erythropoietic porphyria. Proc Natl Acad Sci U S A (1974) 0.89
PRESENT STATUS OF THE EHRLICH ALDEHYDE REACTION FOR URINARY PORPHOBILINOGEN. JAMA (1964) 0.88
Enzymatic defects in hepatic porphyria. Preliminary observations in patients with porphyria cutanea tarda and variegate porphyria. Enzyme (1973) 0.87
Editorial: Hematin and porphyria. N Engl J Med (1975) 0.86
Hematin treatment of acute porphyria. Early remission of an almost fatal relapse. JAMA (1976) 0.84
The Hoesch test: bedside screening for urinary porphobilinogen in patients with suspected porphyria. Clin Chem (1974) 0.84
Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores. Nature (1989) 5.10
Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3. Genes Dev (1999) 2.91
How well are complete dentures copied? Br Dent J (1998) 2.58
B cell stimulatory factor-1/interleukin-4 mRNA is expressed by normal and transformed mast cells. Cell (1987) 2.44
Tongue control of upper complete dentures: a clinical hint. Br Dent J (1991) 1.94
Stat6 is necessary and sufficient for IL-4's role in Th2 differentiation and cell expansion. J Immunol (2001) 1.93
Sildenafil (Viagra) prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium current. Circulation (2000) 1.91
Capillary LC-MS2 at the attomole level for monitoring and discovering endogenous peptides in microdialysis samples collected in vivo. Anal Chem (2001) 1.71
Bile porphyrin analysis in the evaluation of variegate porphyria. N Engl J Med (1991) 1.64
Stat5 as a target for regulation by extracellular matrix. J Biol Chem (1995) 1.61
Quantitative Differentiation of Minute Amounts of the Coproporphyrin Isomers (I and III) Based on Fluorescence Behavior. Science (1946) 1.50
Cycle length dynamics at the onset of postinfarction ventricular tachycardias induced in canines: dependence on interval-dependent excitation properties of the reentrant substrate. J Cardiovasc Electrophysiol (2000) 1.48
The serum porphobilinogen and hepatic porphobilinogen deaminase in normal and porphyric individuals. J Lab Clin Med (1971) 1.47
Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease. Clin Sci (Lond) (1998) 1.46
THE CONVERSION OF HEMATIN TO BILIRUBIN FOLLOWING INTRAVENOUS ADMINISTRATION IN HUMAN SUBJECTS. J Clin Invest (1945) 1.46
Onset of manifestations of hepatic porphyria in relation to the influence of female sex hormones. Arch Intern Med (1966) 1.43
Porphyria variegata and porphyria cutanea tarda in siblings: chemical and genetic aspects. Proc Natl Acad Sci U S A (1975) 1.43
Radioimmunoassay of mammalian type-C polypeptides. IV. Characterization of woolly monkey and gibbon viral antigens. Int J Cancer (1973) 1.42
Potential dangers of laparoscopic insufflator. Lancet (1992) 1.39
Successful use of size-mismatched liver allografts in children by delayed primary closure of the abdominal wall. Br J Surg (1996) 1.39
A safe simple method for removal of the gallbladder through the umbilical trocar site during laparoscopic surgery. J Laparoendosc Surg (1994) 1.39
A survey of complete denture prosthetics for the elderly, the handicapped and difficult patients. Br Dent J (1992) 1.37
The role of Stat3 in apoptosis and mammary gland involution. Conditional deletion of Stat3. Adv Exp Med Biol (2000) 1.34
Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders. Circulation (2000) 1.33
Repression of the overproduction of porphyrin precursors in acute intermittent porphyria by intravenous infusions of hematin. Proc Natl Acad Sci U S A (1971) 1.33
Efficient BLG-Cre mediated gene deletion in the mammary gland. Transgenic Res (1998) 1.33
The clinical porphyrias. Semin Hematol (1968) 1.28
NF-kappaB inhibits apoptosis in murine mammary epithelia. J Biol Chem (2000) 1.25
Epicardial and endocardial mapping of ventricular tachycardia in patients with myocardial infarction. Is the origin of the tachycardia always subendocardially localized? Circulation (1991) 1.25
Regulation of the sheep beta-lactoglobulin gene by lactogenic hormones is mediated by a transcription factor that binds an interferon-gamma activation site-related element. Mol Endocrinol (1994) 1.24
Effect of hematin in acute porphyric relapse. Ann Intern Med (1973) 1.19
Transitory renal failure following rapid administration of a relatively large amount of hematin in a patient with acute intermittent porphyria in clinical remission. Acta Med Scand (1978) 1.17
Differential activation of STATs 3 and 5 during mammary gland development. FEBS Lett (1996) 1.17
Placenta growth factor (PlGF) induces vascular endothelial growth factor (VEGF) secretion from mononuclear cells and is co-expressed with VEGF in synovial fluid. Clin Exp Immunol (2000) 1.16
Transient inhibition of interleukin 4 signaling by T cell receptor ligation. J Exp Med (2000) 1.16
Effects of hematin in hepatic porphyria. Further studies. Ann Intern Med (1975) 1.14
Peripheral blood mononuclear cells from patients with rheumatoid arthritis spontaneously secrete vascular endothelial growth factor (VEGF): specific up-regulation by tumour necrosis factor-alpha (TNF-alpha) in synovial fluid. Clin Exp Immunol (1999) 1.14
DNA chip technology. J Pathol (1999) 1.13
Identification and characterisation of a developmentally regulated mammalian gene that utilises -1 programmed ribosomal frameshifting. Nucleic Acids Res (2001) 1.12
Activated human neutrophils express vascular endothelial growth factor (VEGF). Cytokine (1998) 1.10
Characterization of a nucleoside/proton symporter in procyclic Trypanosoma brucei brucei. J Biol Chem (1998) 1.08
Use of hematin in the acute attack of the "inducible" hepatic prophyrias. Adv Intern Med (1978) 1.07
Mortality in patients with acute intermittent porphyria requiring hospitalization: a United States case series. Am J Med Genet (1996) 1.07
The structure and expression of the preproenkephalin gene. Nucleic Acids Res (1982) 1.06
Differential regulation of nucleoside and nucleobase transporters in Crithidia fasciculata and Trypanosoma brucei brucei. Mol Biochem Parasitol (2000) 1.05
Apoptosis: the germs of death. Nat Cell Biol (1999) 1.05
Collagen-hyaluronic acid scaffolds for adipose tissue engineering. Acta Biomater (2010) 1.04
Cardiac responses to electrical stimulation of discrete loci in canine atrial and ventricular ganglionated plexi. Am J Physiol (1990) 1.04
Separation of bile pigments by thin layer chromatography. J Chromatogr (1968) 1.03
A new method of interpretation of the ferric chloride oxidation patterns of the urobilinoids. Arch Biochem Biophys (1969) 1.02
The mammary factor MPBF is a prolactin-induced transcriptional regulator which binds to STAT factor recognition sites. FEBS Lett (1994) 1.02
Mass spectrometry and ferric chloride oxidation applied to urobilinoid structures. Arch Biochem Biophys (1969) 1.01
A novel cell culture model for studying differentiation and apoptosis in the mouse mammary gland. Breast Cancer Res (2000) 1.01
A novel role for IRF-1 as a suppressor of apoptosis. Oncogene (2000) 1.00
Posttransplant problems requiring regrafting: an analysis of 72 patients with 96 liver retransplants. Transplant Proc (1995) 0.98
Environmental chemical exposures and disturbances of heme synthesis. Environ Health Perspect (1997) 0.98
The isolation of crystalline i-urobilinogen (mesobilirubinogen) from feces. Comparison with crystalline d-urobilinogen (H44) and seprartion of natural i-urobilin into optically active components. J Biol Chem (1966) 0.98
Rising incidence of post-transplant lymphoproliferative disease in kidney transplant recipients. Br J Surg (2001) 0.96
Transcripts from an aberrantly re-arranged human T-cell receptor beta-chain gene. EMBO J (1985) 0.96
Regulation of surface and soluble TNF receptor expression on human monocytes and synovial fluid macrophages by IL-4 and IL-10. J Immunol (1996) 0.96
p53-dependent apoptosis induced by proteasome inhibition in mammary epithelial cells. Cell Death Differ (2001) 0.95
Isolation of porphyrins from porphyria urine by preparative thin-layer chromatography. J Chromatogr (1968) 0.95
NF-kappaB and apoptosis in mammary epithelial cells. J Mammary Gland Biol Neoplasia (1999) 0.95
The heart reinnervates after transplantation. Ann Thorac Surg (2000) 0.95
Stability of delta-aminolevulinic acid and porphobilinogen in urine under varying conditions. Clin Chem (1968) 0.95
Effects of sulfinpyrazone on early graft closure after myocardial revascularization. Am J Cardiol (1982) 0.95
Letter: Phialophora mutabilis endocarditis. Ann Intern Med (1973) 0.94
Randomized, prospective trial of cimetidine and ranitidine for control of intragastric pH in the critically ill. Surgery (1985) 0.94
Uroporphyrinogen I synthase from human erythrocytes: separation, purification, and properties of isoenzymes. Proc Natl Acad Sci U S A (1979) 0.94
Biomimetic collagen scaffolds with anisotropic pore architecture. Acta Biomater (2011) 0.94
Negative inotropic and chronotropic effects of oxytocin. Hypertension (2001) 0.93
On the existence and structure of a new urobilin of molecular weight 592. Proc Natl Acad Sci U S A (1967) 0.92
Cis-urocanic acid synergizes with histamine for increased PGE2 production by human keratinocytes: link to indomethacin-inhibitable UVB-induced immunosuppression. Photochem Photobiol (1995) 0.91
Enterohepatic circulation and conversion of protoporphyrin to bile pigment in man. Proc Soc Exp Biol Med (1968) 0.91
Differential increase in taurine levels by low-dose ethanol in the dorsal and ventral striatum revealed by microdialysis with on-line capillary electrophoresis. Alcohol Clin Exp Res (2004) 0.91
The rate of intravenous cocaine administration alters c-fos mRNA expression and the temporal dynamics of dopamine, but not glutamate, overflow in the striatum. Brain Res (2008) 0.91
The role of personality in the management of complete denture patients. Br Dent J (1984) 0.90
Finite element analysis of fixed prostheses attached to osseointegrated implants. Quintessence Int (1990) 0.90
The Separation of Porphobilinogen and an Ehrlich Negative Precursor of Uroporphyrin. Science (1952) 0.90
Regional distribution of atrial electrical changes induced by stimulation of extracardiac and intracardiac neural elements. J Thorac Cardiovasc Surg (1995) 0.90
THE RELATION OF METHEMOGLOBIN TO THE CYANOSIS OBSERVED AFTER SULFANILAMIDE ADMINISTRATION. J Clin Invest (1940) 0.90
Markedly different effects on ventricular remodeling result in a decrease in inducibility of ventricular arrhythmias. J Am Coll Cardiol (1994) 0.89
Repression by hematin of porphyrin biosynthesis in erythrocyte precursors in congenital erythropoietic porphyria. Proc Natl Acad Sci U S A (1974) 0.89